Organon’s Nexplanon can now be implanted for up to five years after the FDA approved a supplemental New Drug Application by ...

Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...

Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...

Many Europeans, government officials included, believe that President Donald Trump is, at minimum, an unpredictable autocrat ...

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.

Many Nigerian women are decisively setting aside long-held cultural and religious beliefs to embrace modern family planning methods, citing the need to prioritise their health and contribute ...

Health news and commentary gathered by MedPage Today staff ...

There is some concern that medications – such as Tirzepatide (Mounjaro) and Semaglutide – may reduce the absorption of these tablets. The NHS says: "This could lead to irregular bleeding and may ...

The potential $10-billion deal has split the market, pitting those who trust chairman Dilip Shanghvi’s track record of value ...

Women’s health is often surrounded by misinformation, much of it passed down through word of mouth or amplified online. To ...

Media reports this week suggested that Sun Pharma is in discussions with lenders to arrange financing for the acquisition and has submitted non-binding bids, which could value Organon at over $10 ...